Astrazeneca plc
Held by 15 tracked managers as of Q2 2026 · CUSIP ⓘCUSIP: A 9-character ID for one specific security - one share class of one company, or one bond. Tickers can change and can mean different things in different countries; a CUSIP always identifies exactly the same security, which is why filings use it. Guide 046353108, G0593M107 · Sector ⓘGICS sectors: The 11-sector system most investors know (Global Industry Classification Standard): Technology, Health Care, Financials and so on. This site assigns each company a GICS-style sector from its SIC code, with a few hand corrections, so sector pages match the names investors expect. Guide
In plain English: 15 of the investors we track own this stock. In the latest quarter, 6 of them bought more of it and 8 sold some or all of theirs (1 bought it for the first time). That tells you what they did last quarter — not what the stock will do next.
Educational and informational only, not personalized investment advice. Based on public filings that may be delayed or contain errors; verify with the original filings. Disclaimer
Managers holding
15
+1 vs last quarter (like-for-like)
Total value held
$11.70B
Across tracked managers
Average weight ⓘOn average, how big this stock is in the portfolios that own it (its share of each manager's reported portfolio value).
1.5%
Of each manager's book
QoQ value ⓘLike-for-like: only managers that filed both quarters are compared, so a manager filing late (or confidentially) does not look like buying or selling. Includes price changes.
+$153.65M
+2.9% vs last quarter
Net shares bought
+1.9M
Est. net flow +$352.01M
Quarter activity
6 bought · 8 sold
1 new · 0 sold out
Tracked capital in this stock
Total value held (area) and number of managers (line). Dips can mean a large holder filed that quarter confidentially (e.g. Norges Bank in Q1/Q3).
Aggregate buying and selling
Net share change reported each quarter
Who owns AZN?
🔒 The 'who added and who trimmed' chart is a Plus feature
You're viewing the Free plan. Upgrade to unlock The 'who added and who trimmed' chart — every paid plan starts with a 7-day free trial, and you can cancel in two clicks.
Who owns AZN? — Q2 2026
Holders ranked by position size, with each one's quarter-over-quarter change.
Column filters
| # | Manager | Fund | Shares | Value ↓ | % of their portfolio | QoQ | Δ shares | Δ shares % | Est. Δ value ⓘChange in shares × this quarter's price |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Norges Bank | Norges Bank Investment Management | 33.86M | $6.33B | 0.6% | — | — | — | — |
| 2 | Ken Fisher | Fisher Asset Management | 11.15M | $2.11B | 0.6% | Added | +300.6K | +2.8% | +$57.00M |
| 3 | Causeway | Causeway Capital Management | 9.36M | $1.75B | 19.0% | Added | +1.9M | +26.1% | +$362.32M |
| 4 | Boston Partners | Boston Partners Global Investors | 3.18M | $597.39M | 0.5% | Added | +1.1M | +51.8% | +$203.74M |
| 5 | David Shaw | D.E. Shaw & Co. | 1.09M | $207.56M | 0.1% | Added | +1.1M | +4277.5% | +$202.82M |
| 6 | Ken Griffin | Citadel Advisors | 970.04K | $183.94M | 0.1% | Reduced | -899.8K | -48.1% | -$170.61M |
| 7 | Steve Cohen | Point72 Asset Management | 711.55K | $134.92M | 0.2% | Reduced | -522.4K | -42.3% | -$99.06M |
| 8 | Parnassus Investments | Parnassus Investments LLC | 629.16K | $119.30M | 0.3% | Reduced | -13.0K | -2.0% | -$2.46M |
| 9 | Israel Englander | Millennium Management | 581.91K | $110.34M | 0.1% | Reduced | -720.7K | -55.3% | -$136.67M |
| 10 | Two Sigma | Two Sigma Investments | 329.09K | $62.40M | 0.0% | Added | +126.1K | +62.1% | +$23.90M |
| 11 | Larry Robbins | Glenview Capital | 184.28K | $34.94M | 0.7% | New | +184.3K | — | +$34.94M |
| 12 | Fred Alger | Fred Alger Management | 138.80K | $26.26M | 0.1% | Reduced | -630.0K | -81.9% | -$119.18M |
| 13 | Dodge & Cox | Dodge & Cox | 55.95K | $10.61M | 0.0% | Reduced | -1.5K | -2.7% | -$289.17K |
| 14 | Ron Baron | Baron Capital (BAMCO) | 47.84K | $9.07M | 0.0% | Reduced | -16.0K | -25.1% | -$3.03M |
| 15 | Polen Capital | Polen Capital Management | 18.62K | $3.51M | 0.0% | Reduced | -7.4K | -28.5% | -$1.40M |
Column filters
No tracked manager sold out of this stock this quarter.
Politician trades
Column filters
| Politician | Date | Ticker | Asset | Type | Reported range ⓘThe dollar range the politician reported. Exact amounts are not disclosed. | Est. size ⓘOur estimate only: the midpoint of the reported range. | Owner | Account ⓘSubholding Of: the account the trade was in, as named on the report (e.g. an IRA or a brokerage account). The same stock bought on the same day in different accounts is a separate trade in each account. | Filed ↓ | Filing delay ⓘDays between the trade and the report. Over 45 days is late under the STOCK Act. | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Julia Letlow Politician | Dec 8, 2025 | AZN | AstraZeneca PLC - American Depositary Shares (AZN) [ST] | Purchase | $1,001 - $15,000 | Est. $8,000 (midpoint of reported range $1,001–$15,000) | Self | Merrill Lynch Investment Account #025 | Jan 13, 2026 | 36 days | PTR ↗ |
| Gil Cisneros Politician | Dec 18, 2025 | AZN | AstraZeneca PLC - American Depositary Shares (AZN) [ST] | Purchase | $1,001 - $15,000 | Est. $8,000 (midpoint of reported range $1,001–$15,000) | Self | 150 Main Street Trust > Bank of America | Jan 12, 2026 | 25 days | PTR ↗ |
| Gil Cisneros Politician | Nov 19, 2025 | AZN | AstraZeneca PLC - American Depositary Shares (AZN) [ST] | Purchase | $1,001 - $15,000 | Est. $8,000 (midpoint of reported range $1,001–$15,000) | Self | 150 Main Street Trust > Bank of America | Dec 15, 2025 | 26 days | PTR ↗ |
| Lisa McClain Politician | Oct 31, 2025 | AZN | AstraZeneca PLC - American Depositary Shares (AZN) [ST] | Sale | $1,001 - $15,000 | Est. $8,000 (midpoint of reported range $1,001–$15,000) | Spouse | Charles Schwab 401K > Schwab 893 | Nov 21, 2025 | 21 days | PTR ↗ |
| Lisa McClain Politician | Oct 30, 2025 | AZN | AstraZeneca PLC - American Depositary Shares (AZN) [ST] | Purchase | $1,001 - $15,000 | Est. $8,000 (midpoint of reported range $1,001–$15,000) | Spouse | Charles Schwab 401K > Schwab 893 | Nov 21, 2025 | 22 days | PTR ↗ |
| Lisa McClain Politician | Oct 30, 2025 | AZN | AstraZeneca PLC - American Depositary Shares (AZN) [ST] | Sale | $1,001 - $15,000 | Est. $8,000 (midpoint of reported range $1,001–$15,000) | Spouse | Charles Schwab Brokerage Account 924 | Nov 21, 2025 | 22 days | PTR ↗ |
| Gil Cisneros Politician | Oct 21, 2025 | AZN | AstraZeneca PLC - American Depositary Shares (AZN) [ST] | Purchase | $1,001 - $15,000 | Est. $8,000 (midpoint of reported range $1,001–$15,000) | Self | 150 Main Street Trust > Bank of America | Nov 18, 2025 | 28 days | PTR ↗ |
| Val T. Hoyle Politician | Sep 23, 2025 | AZN | AstraZeneca PLC - American Depositary Shares (AZN) [ST] | Sale | $1,001 - $15,000 | Est. $8,000 (midpoint of reported range $1,001–$15,000) | Spouse | Fidelity Rollover IRA | Oct 10, 2025 | 17 days | PTR ↗ |
| Val T. Hoyle Politician | Oct 29, 2024 | AZN | AstraZeneca PLC - American Depositary Shares (AZN) [ST] | Purchase | $1,001 - $15,000 | Est. $8,000 (midpoint of reported range $1,001–$15,000) | Spouse | Fidelity Rollover IRA | Sep 12, 2025 | 318 days Late | PTR ↗ |
| Lisa McClain Politician | Jun 17, 2025 | AZN | AstraZeneca PLC - American Depositary Shares (AZN) [ST] | Sale (partial) | $1,001 - $15,000 | Est. $8,000 (midpoint of reported range $1,001–$15,000) | Spouse | Charles Schwab Brokerage Account 924 | Aug 13, 2025 | 57 days Late | PTR ↗ |
| Lisa McClain Politician | Jun 9, 2025 | AZN | AstraZeneca PLC - American Depositary Shares (AZN) [ST] | Purchase | $1,001 - $15,000 | Est. $8,000 (midpoint of reported range $1,001–$15,000) | Spouse | Charles Schwab Brokerage Account 924 | Aug 13, 2025 | 65 days Late | PTR ↗ |
| Lisa McClain Politician | Jul 22, 2025 | AZN | AstraZeneca PLC - American Depositary Shares (AZN) [ST] | Purchase | $1,001 - $15,000 | Est. $8,000 (midpoint of reported range $1,001–$15,000) | Spouse | Charles Schwab Brokerage Account 924 | Aug 13, 2025 | 22 days | PTR ↗ |
| Bruce Westerman Politician | Apr 21, 2025 | AZN | AstraZeneca PLC - American Depositary Shares (AZN) [ST] | Sale | $1,001 - $15,000 | Est. $8,000 (midpoint of reported range $1,001–$15,000) | Self | Fisher IRA | May 12, 2025 | 21 days | PTR ↗ |
| Bruce Westerman Politician | Mar 3, 2025 | AZN | AstraZeneca PLC - American Depositary Shares (AZN) [ST] | Purchase | $1,001 - $15,000 | Est. $8,000 (midpoint of reported range $1,001–$15,000) | Self | Fisher IRA | Apr 16, 2025 | 44 days | PTR ↗ |